


Pierre Fabre Oncology Email Formats
Pharmaceutical Manufacturing • Castres, Occitanie, France • 51-100 Employees
Pierre Fabre Oncology Email Formats
Pierre Fabre Oncology uses 1 email format. The most common is {first name}.{last name} (e.g., john.doe@pierre-fabre.com), used 100% of the time.
| Format | Example | Percentage |
|---|---|---|
{first name}.{last name} | john.doe@pierre-fabre.com | 100% |
Key Contacts at Pierre Fabre Oncology
Elena Medko
Director Clinical Development
Jean-Baptiste Lannaud Casamayou
Project Director
Sébastien Jeay
Program Director, Oncology Drug Discovery
Olivier Bourges
Global Medical Director Top 5 Countries
Raf Salim
Oncology Account Director
Simon Fitzgerald
Oncology Account Director - Melanoma & Colorectal Cancer
Company overview
| Headquarters | Castres, Occitanie, France |
| Website | |
| NAICS | 3254 |
| Keywords | Lung Cancer, Colorectal Cancer, Breast Cancer, Oncology, CRC, Melanoma, Bladder Cancer, Ptld Ebv+ |
| Founded | 1962 |
| Employees | 51-100 |
| Socials |
About Pierre Fabre Oncology
Pierre Fabre Laboratories is one of Europe's leading pharmaceutical companies. For over 40 years, it has established itself as an international player in oncology, mastering the entire value chain from R&D to marketing. Its portfolio of oncology specialties covers colorectal, breast, lung and skin cancers, as well as certain hematologic malignancies and precancerous dermatological conditions such as actinic keratosis. In 2023, its oncology revenue amounted to nearly 500 million euros, over 90% of which was generated outside France. In 2023, Pierre Fabre Laboratories posted 2.83 billion euros in revenue, 70% of which came from international sales in 120 countries. Its portfolio includes several international brands and medical franchises such as Pierre Fabre Oncologie, Pierre Fabre Dermatologie, Pierre Fabre Pharma Care, Eau Thermale Avène, Ducray, A-Derma, Klorane, René Furterer and Même Cosmetics. Historically based in the southwest of France and manufacturing 95% of its products in France, Pierre Fabre Laboratories employs over 10,000 people worldwide.Its annual R&D budget amounts to nearly 200 million euros, of which about 50% is dedicated to targeted therapies in oncology and 40% to skin health and care solutions. Pierre Fabre Laboratories' majority shareholder (86%) is the eponymous Foundation, which is recognized by the French government as being a public–interest foundation. This capital structure guarantees the company's independence and long-term vision. Dividends paid to the Pierre Fabre Foundation enable it to design and finance humanitarian healthcare-access programs in developing countries. Employees are the company's secondary shareholder, through an international employee shareholding plan. Pierre Fabre Laboratories’ sustainability policy has been assessed by the independent AFNOR Certification body and has been awarded the "Exemplary" level of its CSR label (ISO 26 000 standard for sustainable development).
Employees by Management Level
Total employees: 51-100
Seniority
Employees
Employees by Department
Pierre Fabre Oncology has 41 employees across 9 departments.
Departments
Number of employees
Funding Data
Pierre Fabre Oncology has never raised funding before.
Frequently asked questions
4.8
40,000 users



